1. Home
  2. MCO vs TAK Comparison

MCO vs TAK Comparison

Compare MCO & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moody's Corporation

MCO

Moody's Corporation

N/A

Current Price

$470.14

Market Cap

83.4B

Sector

Finance

ML Signal

N/A

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

N/A

Current Price

$21.82

Market Cap

69.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MCO
TAK
Founded
1900
1781
Country
United States
Japan
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.4B
69.1B
IPO Year
1998
2007

Fundamental Metrics

Financial Performance
Metric
MCO
TAK
Price
$470.14
$21.82
Analyst Decision
Buy
Strong Buy
Analyst Count
24
3
Target Price
★ $553.67
$24.48
AVG Volume (30 Days)
765.2K
★ 3.1M
Earning Date
10-21-2026
10-29-2026
Dividend Yield
0.87%
★ 1.12%
EPS Growth
★ 21.40
N/A
EPS
★ 12.98
N/A
Revenue
★ $4,204,100,000.00
N/A
Revenue This Year
$6.50
$4.79
Revenue Next Year
$6.70
$2.44
P/E Ratio
★ $36.35
$41.25
Revenue Growth
N/A
N/A
52 Week Low
$402.28
$14.16
52 Week High
$546.88
$21.86

Technical Indicators

Market Signals
Indicator
MCO
TAK
Relative Strength Index (RSI) 38.39 69.50
Support Level $460.33 $17.66
Resistance Level $476.73 N/A
Average True Range (ATR) 12.25 0.33
MACD -5.50 -0.01
Stochastic Oscillator 3.58 82.22

Price Performance

Historical Comparison
MCO
TAK

About MCO Moody's Corporation

Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed-income securities. The ratings segment, Moody's Investors Service, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's profit and often (depending on bond issuance levels) a majority of the firm's revenue. The other segment, Moody's Analytics, consists of decision solutions, research and insights, and data and information.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Share on Social Networks: